Sequential doxorubicin plus vinorelbine (AV) followed by docetaxel plus carboplatin (DC) as neoadjuvant chemotherapy for advanced breast cancer (BC)

被引：0
|
作者：
Santisteban, Marta
De la Cruz, Susana
Sola, Jesus Javier
Aramendia, Jose Manuel
Espinos, Jaime
Garran, Cristina
Martinez-Regueira, Fernando
Zornoza, Gerardo
Fernandez-Hidalgo, Oscar
Nieto, Yago
机构：
[1] Clin Univ Navarra, Clin Oncol, Pamplona, Spain
[2] Clin Univ Navarra, Breast Dis Unit, Pamplona, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy (NAC) consisting in dose-dense doxorubicin plus cyclophosphamide followed by cisplatin plus taxane for locoregional advanced triple-negative breast cancer (LATNBC)
    Diaz-Correa, E.
    Singh, C.
    Pereira, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Results of clinical endpoints of a randomized phase It trial with doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as primary systemic therapy for early breast cancer
    Schneeweiss, A.
    Ruiz, A.
    Rovira, P.
    Bottini, A.
    Manikhas, A.
    Wacker, J.
    Schumacher, T.
    Wolf, M.
    Segui, M.
    Sinn, P.
    Kennedy, L.
    Mansouri, K.
    Bauknecht, T.
    [J]. BREAST, 2009, 18 : S63 - S63
  • [43] Neoadjuvant bevacizumab with weekly nanoparticle albumin bound (nab)-paclitaxel plus carboplatin followed by doxorubicin plus cyclophosphamide (AC) for triple negative breast cancer.
    Snider, J. N.
    Allen, J. W.
    Young, R.
    Schwartzberg, L.
    Javed, Y.
    Jahanzeb, M.
    Sachdev, J. C.
    [J]. CANCER RESEARCH, 2012, 72
  • [44] Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines
    Martí, JL
    Bueso, P
    Mayordomo, JI
    Isla, MD
    Saenz, A
    Escudero, P
    Murillo, L
    Filipovich, E
    Andres, R
    Tres, A
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (08) : 1061 - 1065
  • [45] Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
    Angioli, Roberto
    Plotti, Francesco
    Terranova, Corrado
    Angelucci, Michela
    Oronzi, Irma
    Montera, Roberto
    Damiani, Patrizio
    Cafa, Ester Valentina
    Guzzo, Federica
    Montone, Eva
    Ricciardi, Roberto
    Aloisi, Alessia
    Hyseni, Entela
    Luvero, Daniela
    Scaletta, Giuseppe
    Capriglione, Stella
    Lopez, Salvatore
    Miranda, Andrea
    Destri, Marta Li
    Panici, Pierluigi Benedetti
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer
    Takahiro Yoneyama
    Atsushi Imai
    Shingo Hatakeyama
    Yasuhiro Hashimoto
    Takuya Koie
    Chikara Ohyama
    [J]. International Journal of Clinical Oncology, 2015, 20 : 1179 - 1184
  • [47] Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer
    Limentani, Steven A.
    Brufsky, Adam M.
    Erban, John K.
    Jahanzeb, Mohammed
    Lewis, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1232 - 1238
  • [48] Liposome-encapsulated doxorubicin plus cyclophosphamide followed by trastuzumab plus docetaxel as neoadjuvant therapy for HER2-positive breast cancer (BC): A multicenter single-arm phase II study
    Saracchini, Silvana
    Foltran, Luisa
    Sulfaro, Sandro
    Tuccia, Fausto
    Del Conte, Alessandro
    Bertolla, Manuella
    Bassini, Anna
    Micheli, Elvia
    Manente, Stefania
    Gusso, Giuseppina
    Baresic, Tania
    Tumoio, Salvatore
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Neoadjuvant administration of gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in large or locally advanced operable breast cancer: a phase II study.
    Chacko, RT
    Julka, PK
    Parshad, R
    Nair, A
    Nag, S
    Dhindsa, N
    Koppiker, CB
    Nair, S
    Abhyankar, JR
    Dawar, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S109 - S110
  • [50] Doxorubicin plus paclitaxel in advanced breast cancer
    Dombernowsky, P
    Boesgaard, M
    Andersen, E
    Jensen, PV
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (05) : 15 - 18
12345